Literature DB >> 2936582

Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.

E Goormans, A Dalhoff, B Kazzaz, J Branolte.   

Abstract

Penetration activities of ciprofloxacin into female genital tract tissues were studied following a single oral administration of 500 mg and an intravenous injection of 100 mg. Serum and tissue concentrations were within the same order of magnitude 1 and 3 h after oral administration; 3 h after intake of ciprofloxacin, however, tissue concentrations exceeded the corresponding serum levels twofold. Similarly, tissue concentrations following intravenous injection exceeded the corresponding serum levels by 60-190% 0.5 h after injection and were consistently higher throughout the study period of 2 h. These data confirm that ciprofloxacin disposition is characterized by a remarkably pronounced diffusion into the extravascular space, generating tissue levels exceeding the minimal inhibitory concentrations of most pathogens severalfold.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936582     DOI: 10.1159/000238383

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  9 in total

Review 1.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 2.  Quinolone antibacterial agents for the treatment of genitourinary tract infections.

Authors:  T J Babinchak; R J Fass
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 3.  Overview of clinical experience with ciprofloxacin.

Authors:  A P Ball
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

4.  Ciprofloxacin concentrations in tonsils following single or multiple administrations.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Is pelvic inflammatory disease an indication for treatment with ciprofloxacin?

Authors:  D Hägele; V Chyský
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 6.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Ciprofloxacin pharmacokinetics in patients with cystic fibrosis.

Authors:  S W Bender; A Dalhoff; P M Shah; R Strehl; H G Posselt
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.